Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:European urology 2020-11, Vol.78 (5), p.765-766
Hauptverfasser: Chin, Joseph L., Bauman, Glenn S.
Format: Artikel
Sprache:eng
Schlagworte:
Androgen Antagonists
Humans
Male
Prostatic Neoplasms - therapy
Risk Assessment
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 766
container_issue 5
container_start_page 765
container_title European urology
container_volume 78
creator Chin, Joseph L.
Bauman, Glenn S.
description
doi_str_mv 10.1016/j.eururo.2020.06.016
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2419419747</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0302283820304450</els_id><sourcerecordid>2419419747</sourcerecordid><originalsourceid>FETCH-LOGICAL-c311t-3cfdce4465bc11fbcf0aae31331c17af2a04e762de530155be709a16e28999323</originalsourceid><addsrcrecordid>eNp9UV1v1DAQtBCIHoV_gJAfeUlY2_nsA9JxAlrpENVRni2fswEfiX21naLjz_BXcZrCI5Ila2dnvN4ZQl4yyBmw6s0hx8lP3uUcOORQ5Ql8RFasqUVWlxU8JisQwDPeiOaMPAvhAACibMVTciZ4BWVTNivye4cX9B1a7E0MVNmO7kz4Eajr6bU3o_IneuNRxRFt6vfO00vz7XvmE4lunVaD-YXdve6-Gk503d0pqxN47V2IKiLdzLW_oGtLr2xEb1U0zqqBfpqGaDoTtDkOxs6zvpxCxDH1Nd3hncGfz8mTXg0BXzzc5-Trh_c3m8ts-_nj1Wa9zbRgLGZC953GoqjKvWas3-selELBhGCa1arnCgqsK95hKYCV5R5raBWrkDdt2wouzsnr5d2jd7cThijH9C8cBmXRTUHygrXp1EWdqMVC1WnB4LGXx8UpyUDO0ciDXKKRczQSKpnAJHv1MGHaj9j9E_3NIhHeLgRMe6bdvUzG4Gyl8aij7Jz5_4Q_yW-kkA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2419419747</pqid></control><display><type>article</type><title>Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><creator>Chin, Joseph L. ; Bauman, Glenn S.</creator><creatorcontrib>Chin, Joseph L. ; Bauman, Glenn S.</creatorcontrib><identifier>ISSN: 0302-2838</identifier><identifier>EISSN: 1873-7560</identifier><identifier>DOI: 10.1016/j.eururo.2020.06.016</identifier><identifier>PMID: 32605858</identifier><language>eng</language><publisher>Switzerland: Elsevier B.V</publisher><subject>Androgen Antagonists ; Humans ; Male ; Prostatic Neoplasms - therapy ; Risk Assessment</subject><ispartof>European urology, 2020-11, Vol.78 (5), p.765-766</ispartof><rights>2020</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c311t-3cfdce4465bc11fbcf0aae31331c17af2a04e762de530155be709a16e28999323</cites><orcidid>0000-0002-1171-1436</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.eururo.2020.06.016$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3548,27922,27923,45993</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32605858$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Chin, Joseph L.</creatorcontrib><creatorcontrib>Bauman, Glenn S.</creatorcontrib><title>Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review</title><title>European urology</title><addtitle>Eur Urol</addtitle><subject>Androgen Antagonists</subject><subject>Humans</subject><subject>Male</subject><subject>Prostatic Neoplasms - therapy</subject><subject>Risk Assessment</subject><issn>0302-2838</issn><issn>1873-7560</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UV1v1DAQtBCIHoV_gJAfeUlY2_nsA9JxAlrpENVRni2fswEfiX21naLjz_BXcZrCI5Ila2dnvN4ZQl4yyBmw6s0hx8lP3uUcOORQ5Ql8RFasqUVWlxU8JisQwDPeiOaMPAvhAACibMVTciZ4BWVTNivye4cX9B1a7E0MVNmO7kz4Eajr6bU3o_IneuNRxRFt6vfO00vz7XvmE4lunVaD-YXdve6-Gk503d0pqxN47V2IKiLdzLW_oGtLr2xEb1U0zqqBfpqGaDoTtDkOxs6zvpxCxDH1Nd3hncGfz8mTXg0BXzzc5-Trh_c3m8ts-_nj1Wa9zbRgLGZC953GoqjKvWas3-selELBhGCa1arnCgqsK95hKYCV5R5raBWrkDdt2wouzsnr5d2jd7cThijH9C8cBmXRTUHygrXp1EWdqMVC1WnB4LGXx8UpyUDO0ciDXKKRczQSKpnAJHv1MGHaj9j9E_3NIhHeLgRMe6bdvUzG4Gyl8aij7Jz5_4Q_yW-kkA</recordid><startdate>202011</startdate><enddate>202011</enddate><creator>Chin, Joseph L.</creator><creator>Bauman, Glenn S.</creator><general>Elsevier B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-1171-1436</orcidid></search><sort><creationdate>202011</creationdate><title>Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review</title><author>Chin, Joseph L. ; Bauman, Glenn S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c311t-3cfdce4465bc11fbcf0aae31331c17af2a04e762de530155be709a16e28999323</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Androgen Antagonists</topic><topic>Humans</topic><topic>Male</topic><topic>Prostatic Neoplasms - therapy</topic><topic>Risk Assessment</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Chin, Joseph L.</creatorcontrib><creatorcontrib>Bauman, Glenn S.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European urology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Chin, Joseph L.</au><au>Bauman, Glenn S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review</atitle><jtitle>European urology</jtitle><addtitle>Eur Urol</addtitle><date>2020-11</date><risdate>2020</risdate><volume>78</volume><issue>5</issue><spage>765</spage><epage>766</epage><pages>765-766</pages><issn>0302-2838</issn><eissn>1873-7560</eissn><cop>Switzerland</cop><pub>Elsevier B.V</pub><pmid>32605858</pmid><doi>10.1016/j.eururo.2020.06.016</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-1171-1436</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0302-2838
ispartof European urology, 2020-11, Vol.78 (5), p.765-766
issn 0302-2838
1873-7560
language eng
recordid cdi_proquest_miscellaneous_2419419747
source MEDLINE; ScienceDirect Journals (5 years ago - present)
subjects Androgen Antagonists
Humans
Male
Prostatic Neoplasms - therapy
Risk Assessment
title Re: Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T19%3A16%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Re:%20Benefits%20and%20Risks%20of%20Primary%20Treatments%20for%20High-risk%20Localized%20and%20Locally%20Advanced%20Prostate%20Cancer:%20An%20International%20Multidisciplinary%20Systematic%20Review&rft.jtitle=European%20urology&rft.au=Chin,%20Joseph%20L.&rft.date=2020-11&rft.volume=78&rft.issue=5&rft.spage=765&rft.epage=766&rft.pages=765-766&rft.issn=0302-2838&rft.eissn=1873-7560&rft_id=info:doi/10.1016/j.eururo.2020.06.016&rft_dat=%3Cproquest_cross%3E2419419747%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2419419747&rft_id=info:pmid/32605858&rft_els_id=S0302283820304450&rfr_iscdi=true